Todd C. Davis - 13 Nov 2024 Form 4 Insider Report for Chromocell Therapeutics Corp (CHRO)

Role
Director
Signature
/s/ Francis Knuettel II, under Power of Attorney dated August 1, 2023, from Todd C. Davis
Issuer symbol
CHRO
Transactions as of
13 Nov 2024
Net transactions value
$0
Form type
4
Filing time
15 Nov 2024, 16:22:20 UTC
Previous filing
09 Aug 2024
Next filing
17 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHRO Restricted Stock Units Award +49,605 +23% 263,306 13 Nov 2024 Common Stock 49,605 $0.6400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 13, 2024, the Reporting Person was granted restricted stock units to purchase 49,605 shares of common stock at an exercise price of $0.64 per share, which shall vest on a quarterly basis over a period of six (6) quarters.